Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for influenza in United States

80 results

Sort By:

A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults

Study ID: NCT05518500
Start Date: 2022-08-31
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

75

Intervention / Treatment

Flu Vaccine (Year 1)

Flu Vaccine (Year 2)

Flu Vaccine (Year 3)

Sponsor

The Jackson Laboratory

Source: clinicaltrials.gov

Share:
Add to list

Opioid, HIV and Immune System

Study ID: NCT04304768
Start Date: 2020-11-18
End Date: 2025-05-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

300

Intervention / Treatment

Fluzone Quadrivalent

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

TeleHealth Model to Address Vaccine Hesitancy & Increase Vaccine Completion Among Communities in Southeastern Louisiana

Study ID: NCT05676970
Start Date: 2024-01-01
End Date: 2028-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

360

Intervention / Treatment

Telehealth: Wellness and Vaccination

TeleHealth: Wellness Only

Sponsor

Xavier University of Louisiana.

Source: clinicaltrials.gov

Share:
Add to list

Live Attenuated Influenza Vaccine As a Nasal Model for Influenza Infection

Study ID: NCT04164212
Start Date: 2020-09-01
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

25

Intervention / Treatment

Flumist Quadrivalent Nasal Product

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Study ID: NCT05624450
Start Date: 2022-12-13
End Date: 2026-06-19
Study Type

Interventional

Study Phase

Phase3

No. of Participants

2870

Intervention / Treatment

Tozorakimab

Placebo

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Woodsmoke Exposure, Influenza Infection, and Nasal Immunity

Study ID: NCT06841913
Start Date: 2025-03-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

112

Intervention / Treatment

LAIV nasal vaccine is chosen as a model viral infection

Wood smoke

Placebo for LAIV nasal vaccine is chosen as a model viral infection

Placebo for Wood Smoke (clean Air Exposure)

Sponsor

University of North Carolina, Chapel Hill

Source: clinicaltrials.gov

Share:
Add to list

Influenza Human Challenge Model

Study ID: NCT05332899
Start Date: 2022-05-24
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

80

Intervention / Treatment

Influenza Virus Type A H3N2 Challenge

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

Study of Immune Responses to Influenza Vaccination

Study ID: NCT03346772
Start Date: 2017-10-20
End Date: 2026-07-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

75

Intervention / Treatment

Influenza vaccination

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Bone Marrow and Peripheral Blood Immune Responses Study

Study ID: NCT05616546
Start Date: 2023-10-16
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

90

Intervention / Treatment

Vaccine influence

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

Study ID: NCT05869968
Start Date: 2023-03-31
End Date: 2027-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment
Sponsor

Northwell Health

Source: clinicaltrials.gov

Share:
Add to list